# US 2023/0143309 A1 · Pyrrolobenzodiazepine antibody conjugates

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0143309 A1
- Document ID: US20230143309A1
- Status: Published application
- Kind: A1
- Application number: 17/962,610
- Filed: 2022-10-10
- Published: 2023-05-11
- Earliest claimed: 2016-02-10
- Assignees: MedImmune, LLC
- Applicants: Medimmune Limited
- Inventors: Philip Wilson Howard; Elizabeth Dunny; Luke Masterson
- Web page: https://patentgrep.com/patent/US20230143309A1

## CPC

- A61K 47/6867: {the tumour determinant being from a cell of a blood cancer}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K 47/68035: {the drug being a pyrrolobenzodiazepine}
- A61K 47/6849: {the antibody targeting a receptor, a cell surface antigen or a cell surface determinant}
- A61K 47/6851: {the antibody targeting a determinant of a tumour cell}
- A61K 47/6855: {the tumour determinant being from breast cancer cell}
- A61P 35/00: Antineoplastic agents
- C07D 487/04: Ortho-condensed systems
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

A conjugate of formula I: L-(DL)p (I) wherein L is a Ligand unit, DL is a Drug Linker unit of formula II: wherein either: (a) R10 and R11 form a nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are bound; or (b) R11 is OH, and R10 is: p is an integer of from 1 to 20.

## Claims

### Claim at position 1

1-24. (canceled)

### Claim 25

A compound of formula III:
wherein
either:
(a) R10 and R11 form a nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are bound; or
(b) R11 is OH, and R10 is:

### Claim 26 (depends on 25)

A compound according to claim 25 which is A:

### Claim 27 (depends on 25)

A compound according to claim 25 which is B:

### Claim 28 (depends on 25)

A method of synthesis of a conjugate of formula:
L-(DL)p (1)
wherein L is a Ligand unit, DL is a Drug Linker unit of formula is:
wherein
either:
(a) R10 and R11 form a nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are bound; or
(b) R11 is OH, and R10 is:
p is an integer of from 1 to 20
comprising the step of conjugating the compound according to claim 25 with a cell-binding agent.
